GDC-2992 is a small molecule, oral degrader of the androgen receptor, a disease driver in prostate cancer. GDC-2992 has the potential to treat patients with prostate cancer who have developed resistance to current therapies.
MedKoo Cat#: 128840
Name: GDC-2992
CAS#: 2753651-10-2
Chemical Formula: C45H51ClN8O5
Exact Mass: 818.3671
Molecular Weight: 819.40
Elemental Analysis: C, 65.96; H, 6.27; Cl, 4.33; N, 13.68; O, 9.76
The following data is based on the product molecular weight 819.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |